SCHEMBL25430912

SCHEMBL25430912

FC(F)(F)c1ccc(Nc2nccnc2-c2ccc3[nH]nnc3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 19/20 0.47
▸ EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25430955 0.84 TRPV1 (0.46) TRPV1EPHX2
SCHEMBL30544072 0.84 TRPV1 (0.46) TRPV1EPHX2
SCHEMBL25951852 0.82 TRPV1 (0.41) TRPV1EPHX2
SCHEMBL30544130 0.78 TRPV1 (0.37) TRPV1
SCHEMBL25428892 0.78 TRPV1 (0.37) TRPV1
SCHEMBL25428430 0.77 TRPV1 (0.36) TRPV1
SCHEMBL30544022 0.77 TRPV1 (0.36) TRPV1
SCHEMBL25340913 0.75 KIF11 (0.51) TRPV1EPHX2
SCHEMBL30519339 0.75 KIF11 (0.51) TRPV1EPHX2
SCHEMBL25339641 0.74 TRPV1 (0.62) TRPV1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback